IA LYNNE ARANA: Open Payments
NPI 1881356640 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,285 in 63 payments from 19 companies in 2025. Trend: 2023 $1,773 · 2024 $2,261 · 2025 $2,285
Food & beverage: $2,285
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 9 | $279 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $266 |
| Amgen Inc. | 9 | $252 |
| Apellis Pharmaceuticals, Inc. | 2 | $250 |
| Calliditas Therapeutics US Inc. | 4 | $214 |
| AstraZeneca Pharmaceuticals LP | 5 | $209 |
| Travere Therapeutics, Inc. | 3 | $151 |
| AKEBIA THERAPEUTICS INC | 1 | $122 |
| Vantive US Healthcare LLC | 1 | $115 |
| Novo Nordisk Inc | 4 | $102 |
Products named: KRYSTEXXA, Empaveli, TARPEYO, IBSRELA, Kerendia, Filspari, XPHOZAH 30 MG, LOKELMA.
Industry payments across HI — which companies pay providers there.
